| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 58.939 | 87.173 | 88.870 | 93.668 | 155.625 | 215.268 | 207.003 | 351.807 | 380.775 | 371.264 |
| Total Income - EUR | 58.941 | 87.188 | 88.870 | 93.672 | 155.637 | 226.511 | 207.034 | 357.210 | 382.354 | 386.475 |
| Total Expenses - EUR | 39.351 | 48.048 | 54.338 | 38.181 | 57.476 | 78.371 | 68.654 | 74.169 | 72.980 | 110.195 |
| Gross Profit/Loss - EUR | 19.591 | 39.139 | 34.533 | 55.491 | 98.161 | 148.140 | 138.380 | 283.041 | 309.374 | 276.281 |
| Net Profit/Loss - EUR | 17.822 | 37.418 | 32.753 | 54.554 | 96.605 | 146.022 | 136.351 | 279.659 | 305.928 | 264.933 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Transplant Surg Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 33.181 | 28.344 | 21.758 | 18.010 | 81.612 | 54.369 | 40.107 | 26.519 | 12.928 | 111.095 |
| Current Assets | 50.017 | 45.473 | 40.380 | 65.096 | 69.739 | 143.336 | 132.577 | 296.276 | 314.873 | 283.319 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 46.567 | 41.334 | 37.240 | 50.560 | 54.201 | 70.013 | 18.853 | 167.574 | 271.662 | 247.357 |
| Cash | 3.449 | 4.139 | 3.139 | 14.536 | 15.538 | 73.323 | 113.723 | 128.702 | 33.103 | 25.911 |
| Shareholders Funds | 43.196 | 37.864 | 32.980 | 54.606 | 96.656 | 187.094 | 136.399 | 281.684 | 323.946 | 264.982 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 40.002 | 35.953 | 32.376 | 30.869 | 57.402 | 11.914 | 36.285 | 41.111 | 3.854 | 129.432 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Transplant Surg Srl